Diurnal IOP-lowering efficacy and safety of travoprost 0.004% compared with tafluprost 0.0015% in patients with primary open-angle glaucoma or ocular hypertension

Lignende værker

• Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy
  af: Schnober, Dietmar, et al.
  Udgivet: (2015)
• A randomized crossover study comparing tafluprost 0.005% with travoprost 0.004% in patients with normal-tension glaucoma
  af: Mizoguchi, Takanori, et al.
  Udgivet: (2012)
• Efficacy and tolerability of preservative-free tafluprost 0.0015% in Korean patients with glaucoma
  af: Hwang, Young Hoon
  Udgivet: (2014)
• Effects of corneal thickness on the intraocular penetration of travoprost 0.004%
  af: Martinez-de-la-Casa, J M, et al.
  Udgivet: (2012)
• Pooled results of two randomized clinical trials comparing the efficacy and safety of travoprost 0.004%/timolol 0.5% in fixed combination versus concomitant travoprost 0.004% and timolol 0.5%
  af: Gross, Ronald L, et al.
  Udgivet: (2007)